Bio-Techne Company (NASDAQ:TECH) Q1 2025 Earnings Convention Name October 30, 2024 9:00 AM ET
Firm Contributors
David Clair – Vice President-Investor RelationsKim Kelderman – President and Chief Government OfficerJim Hippel – Chief Monetary Officer
Convention Name Contributors
Puneet Souda – Leerink PartnersJacob Johnson – StephensDan Leonard – UBSThomas DeBourcy – Nephron ResearchJustin Bowers – Deutsche BankTom Peterson – BairdMatt Larew – William BlairSung Ji Nam – Scotiabank
Operator
Good morning, and welcome to the Bio-Techne Earnings Convention Name for the First Quarter of Fiscal Yr 2025. Right now, all individuals have been positioned in listen-only mode and the decision might be open for questions following administration’s ready remarks. Throughout our Q&A session, please restrict your self to 1 query and one follow-up.
I might now like to show the decision over to David Clair, Bio-Techne’s Vice President, Investor Relations.
David Clair
Good morning, and thanks for becoming a member of us. On the decision with me this morning are Kim Kelderman, President and Chief Government Officer; and Jim Hippel, Chief Monetary Officer of Bio-Techne.
Earlier than we start, let me briefly cowl our protected harbor assertion. A number of the feedback made throughout this convention name could also be thought-about forward-looking statements, together with beliefs and expectations concerning the firm’s future outcomes.
The corporate’s 10-Okay for fiscal yr 2024 identifies sure components that might trigger the corporate’s precise outcomes to vary materially from these projected within the forward-looking statements made throughout this name. The corporate doesn’t undertake to replace any forward-looking statements due to any new data or future occasions or developments. The ten-Okay, in addition to the corporate’s different SEC filings, can be found on the corporate’s web site inside its Investor Relations part.
Throughout the name, non-GAAP monetary measures could also be used to supply data pertinent to
